Nicole Gifford

ID: 1b83c151-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

Sanofi, Genzyme, and Regeneron Voluntarily Dismiss Dupixent® (Dupilumab) Declaratory Judgment Suit in Massachusetts

Biosimilars Law Bulletin · May 8, 2017

Pfizer Files IPR Petitions on Three More Rituximab® Patents

Biosimilars Law Bulletin · May 3, 2017

Celltrion Submits Application for Herzuma (trastuzumab) in Japan and Launches Truxima (rituximab) in Europe

Biosimilars Law Bulletin · May 2, 2017

Supreme Court Hears Oral Argument in Its First Biosimilar Case

Biosimilars Law Bulletin · April 28, 2017

FDA Approves Fifth Biosimilar – Samsung Bioepis’s Renflexis® (infliximab-abda)

Biosimilars Law Bulletin · April 24, 2017

Practice Areas

Health Care and Life Sciences

Jurisdictions

Washington, D.C.